Linked Life Data

20688444

Source:http://linkedlifedata.com/resource/pubmed/id/20688444

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8-9
pubmed:dateCreated
2010-9-29
pubmed:abstractText
The 18-fluorine-18-fluoro-2-deoxyglucose Positron Emission Tomography coupled with computed tomography is a non invasive exploration. Several studies have shown that PET-CT has superior efficacy over conventional imaging techniques in distinguishing a benign pancreatic tumor from a malignant one. It contributes to the diagnosis of cancer in patients with a doubtful mass, much more in case of chronic pancreatitis. PET-CT is also an important help for the diagnosis of cystic tumors of the pancreas; the results can affect the management strategy. It is interesting for the endocrine tumors, particularly since the emergence of new markers. The aim of this paper is to summarize the role and limitations of 18-F-FDG PET-CT in the management of patients with pancreatic lesions (adenocarcinoma, cystic tumors, endocrine tumors, etc…) concerning the malignancy diagnosis, the detection of metastases, the monitoring after non surgical treatments and to evaluate interpretation difficulties, particularly in case of diabetes or chronic pancreatitis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0399-8320
pubmed:author
pubmed:copyrightInfo
Copyright © 2010. Published by Elsevier Masson SAS.
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
465-74
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions.
pubmed:affiliation
Service de chirurgie digestive et endocrinienne, CHU Hôtel-Dieu, 1 place Alexis-Ricordeau, Nantes cedex 1, France. claire-pery@hotmail.fr
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't